Obi Umeh, MD, MSc, VP, Franchise Global Program Leader at Takeda, discusses interim results from a study investigating mezagitamab for the treatment of patients with IgA nephropathy. This…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
NEW YORK (Reuters Health) – Patients who begin dialysis when kidney disease is at a relatively early stage have an increased risk of dying in the following year,…
NEW YORK (Reuters Health) – Patients who develop acute renal failure (ARF) after undergoing coronary artery bypass grafting have a poorer prognosis if the condition doesn’t resolve within…
NEW YORK (Reuters Health) – The mineral composition of kidney stones reported by commercial laboratories is often inaccurate, investigators at Indiana University, Indianapolis report in the Journal of…
NEW YORK (Reuters Health) – Major surgery often leads to transient thyroid hormone derangements. When it does, short-duration T3 therapy has no apparent benefit, according to a new…
NEW YORK (Reuters Health) – When end-stage renal disease patients receive hemodialysis six times a week, their depressive symptoms and the “vexing problem” of postdialysis fatigue are ameliorated,…
NEW YORK (Reuters Health) – A course of intravenous antibiotic therapy lasting no more than 3 days for hospitalized infants with urinary tract infections is just as successful…
NEW YORK (Reuters Health) – Patients with chronic kidney disease not requiring hemodialysis present a dilemma when it comes to treating concomitant multivessel coronary artery disease (CAD): coronary…
NEW YORK (Reuters Health) – In selected patients with upper tract urothelial carcinoma, endoscopic management offers a nephron-sparing alternative to nephroureterectomy, researchers report in the June issue of…
NEW YORK (Reuters Health) – Extracorporeal shock wave lithotripsy (ESWL) is an effective and safe treatment for renal calculi in children, French researchers report in the June issue…
NEW YORK (Reuters Health) – In patients with chronic kidney disease (CKD) and anemia, targeting higher hemoglobin levels with an erythropoietic agent is not helpful and is very…
